Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.48 |
| ▸ | ACACB | O00763 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | WNT3A | P56704 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | RET | P07949 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | GPR183 | P32249 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12811247 | 0.88 | EGLN2 (0.48) | CYP11B2SCD5ACACBTSHRWNT3A | |
| SCHEMBL20468955 | 0.87 | CYP3A4 (0.51) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL21711129 | 0.86 | CYP11B2 (0.53) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL20469135 | 0.86 | CYP11B2 (0.53) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL30328547 | 0.86 | CYP11B2 (0.48) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL20468954 | 0.86 | CYP11B2 (0.48) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL30042024 | 0.85 | CYP3A4 (0.67) | CYP3A4CYP2C9CYP2D6CYP11B2TSHR | |
| SCHEMBL20468949 | 0.83 | CYP11B2 (0.53) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL8511634 | 0.83 | CYP11B2 (0.53) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 | |
| SCHEMBL20468940 | 0.82 | CYP11B2 (0.53) | CYP3A4CYP2C9CYP2D6CYP11B2SCD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200048267-A1 | OGA INHIBITOR COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2020-02-13 | — | — | US | disclosed |
| WO-2018141984-A1 | OGA INHIBITOR COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2018-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048267-A1 | OGA INHIBITOR COMPOUNDS | OGA, OGT, GRN | CYP3A4 4278/4885CYP2C9 4183/4885CYP2D6 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.